Literature DB >> 8806571

Clonal expansion of human T-cell leukemia virus type II in patients with high proviral load.

A Cimarelli1, C A Duclos, A Gessain, C Casoli, U Bertazzoni.   

Abstract

In previous studies we demonstrated that individuals infected by human T-cell leukemia virus type II (HTLV-II) presented a high degree of variation in proviral load and that the cellular tropism of this virus was expanded in some patients to B-lymphocytes. To understand whether the observed high proviral load could be associated with the clonal expansion of the infected cells, we have studied the mode of integration of HTLV-II in six infected individuals with proviral load higher than 1% of total peripheral blood mononuclear cells (PBMCs). An inverse polymerase chain reaction (PCR) analysis, which allowed the amplification of the region flanking the 5' end of the provirus, was developed for HTLV-II. A single band, corresponding to a monoclonal expansion, was found in four of six patients analyzed, while in the other two patients an oligoclonal type of integration was observed. The results for inverse PCR analysis were confirmed by sequencing the PCR products and showing that the 5' LTR flanking sequences of proviral DNA obtained from the different subjects presented no homology, thus suggesting that no specific site or sequence is required for the integration process of HTLV-II. The results indicate that the HTLV-II high proviral load observed in PBMCs from infected patients is associated with a clonal expansion of HTLV-II-infected cells. This study also suggests that the very high genetic stability of HTLV-II could be explained by viral amplification via clonal expansion rather than by reverse transcription.

Entities:  

Mesh:

Year:  1996        PMID: 8806571     DOI: 10.1006/viro.1996.0487

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  7 in total

1.  Different population dynamics of human T cell lymphotropic virus type II in intravenous drug users compared with endemically infected tribes.

Authors:  M Salemi; M Lewis; J F Egan; W W Hall; J Desmyter; A M Vandamme
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

2.  Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.

Authors:  R Mahieux; C A Pise-Masison; P F Lambert; C Nicot; L De Marchis; A Gessain; P Green; W Hall; J N Brady
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  Isolation and confirmation of human T-cell leukemia virus type 2 from peripheral blood mononuclear cells.

Authors:  Michael D Lairmore; Andy Montgomery
Journal:  Methods Mol Biol       Date:  2005

4.  Intrahost variations in the envelope receptor-binding domain (RBD) of HTLV-1 and STLV-1 primary isolates.

Authors:  Felix J Kim; Madakasira Lavanya; Antoine Gessain; Sandra Gallego; Jean-Luc Battini; Marc Sitbon; Valérie Courgnaud
Journal:  Retrovirology       Date:  2006-05-25       Impact factor: 4.602

Review 5.  HTLV-1 and HTLV-2: highly similar viruses with distinct oncogenic properties.

Authors:  Vincenzo Ciminale; Francesca Rende; Umberto Bertazzoni; Maria G Romanelli
Journal:  Front Microbiol       Date:  2014-07-29       Impact factor: 5.640

Review 6.  Comparative virology of HTLV-1 and HTLV-2.

Authors:  Michael P Martinez; Jacob Al-Saleem; Patrick L Green
Journal:  Retrovirology       Date:  2019-08-07       Impact factor: 4.602

7.  Clonality of HTLV-2 in natural infection.

Authors:  Anat Melamed; Aviva D Witkover; Daniel J Laydon; Rachael Brown; Kristin Ladell; Kelly Miners; Aileen G Rowan; Niall Gormley; David A Price; Graham P Taylor; Edward L Murphy; Charles R M Bangham
Journal:  PLoS Pathog       Date:  2014-03-13       Impact factor: 6.823

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.